Data da publicação:
O CoronaFatos chega ao seu último episódio. Apesar da pandemia ainda não ter acabado, especialistas já apontam sinais de que podemos estar saindo da fase mais aguda dela e entrando em um novo estágio no enfrentamento da Covid-19. Ainda não é possível ter certeza se haverá novas ondas de infecções provocadas pelo coronavírus ou não, mas com a esperança de que dias melhores estejam chegando, especialmente graças às vacinas, o CoronaFatos finaliza um ciclo em uma fase em que temos informação de qualidade sobre as formas de prevenir e combater a doença.
Article
Data da publicação:
A sessão do Centro de Estudos do Instituto Oswaldo Cruz (IOC/Fiocruz) da próxima sexta-feira (4/3) abordará o tema Petrópolis, a cidade imperial do Brasil: história, desenvolvimento sustentável e crises ambientais, com a pesquisadora da Casa de Oswaldo Cruz (COC/Fiocruz), Magali Romero Sá, e o especialista em Direito Ambiental, Marcus de Almeida Lima. Na ocasião, o pesquisador do Laboratório de Virologia Comparada e Ambiental do IOC, José Paulo Gagliardi Leite, atuará como mediador.
Article
Data da publicação:
Countries with high vaccination coverage are adopting a dangerous rhetoric according to which the pandemic is over or almost over. But how can one state that when there are still 70,000 people dying of COVID-19 in a week, worldwide? The warning was issued by the Assistant Director-General for Access to Medicines and Pharmaceutical Products of the World Health Organization (WHO), Brazilian Mariângela Batista Galvão Simão.
Article
Data da publicação:
When he was about to turn 4 years old, Julinho started to attend a day care center near his home. The adaptation was difficult for the adults in the family, who were used to taking care of him all the time. “What if he had a seizure?”, “What if he cried a lot?”, “What if they forgot the medication schedule?”. The questions were frequent. But the boy surprised everyone with his good integration: he didn't seem to miss his mother and grandmother, he was kind to his classmates and encouraged all the time to try new things.
Article
Data da publicação:
In this role for less than five months, the new Ecuador ambassador in Brazil, Carlos Alberto Velástegui, visited Fiocruz last Friday (February 18) to strengthen the ties between his country and the Foundation.
Article
Data da publicação:
The Oswaldo Cruz Foundation (Fiocruz), through the Immunobiological Technology Institute (Biomanguinhos), provides the first doses of the COVID-19 vaccine (recombinant) produced with the national Active Pharmaceutical Ingredient (API). The first batch of national vaccines was released by the internal quality control of Bio-Manguinhos on 2/14.
Article
Data da publicação:
This Thursday (17/2) the Fiocruz Genomic Network released new figures on the lineages and variants of the Sars-CoV-2 virus in Brazil.
Article
Data da publicação:
A Fundação Oswaldo Cruz, por meio do Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos/Fiocruz), disponibiliza para o Ministério da Saúde (MS) as primeiras doses da vacina Covid-19 (recombinante) produzidas com o Ingrediente Farmacêutico Ativo (IFA) nacional. O primeiro lote de vacinas nacionais foi liberado pelo controle de qualidade interno de Bio-Manguinhos/Fiocruz no dia 14 de fevereiro.
Article
Data da publicação:
A Fiocruz Brasília e o Ministério Público do Distrito Federal e Territórios (MPDFT) assinaram, na última sexta-feira (11/2), um acordo de cooperação para o desenvolvimento do projeto Territórios da Construção de Si: processos de desinstitucionalização de jovens e adolescentes pela maioridade. O foco do projeto é a garantia dos direitos de jovens em situação de risco e vulnerabilidade social – em especial, aqueles que se encontram acolhidos em abrigos institucionais da Assistência Social do DF.
Article
Data da publicação:
O CoronaFatos está chegando ao fim da sua temporada e neste episódio o programa faz uma espécie de 'resumão' com tudo o que você precisa saber sobre o atual momento da pandemia de Covid-19. A pandemia ainda não acabou e não é possível ter certeza sobre o caminho que ela tomará.
Article
Data da publicação:
A technological innovation may contribute to the quest for the leprosy elimination, one of the humanity oldest diseases. An international team of scientists, led by the Oswaldo Cruz Institute (IOC/Fiocruz), in partnership with Microsoft AI for Health and the Novartis Foundation, has developed a diagnostic assistant, based on artificial intelligence, which can help identify suspected leprosy lesions. The technology has been called AI4Leprosy.
Article
Data da publicação:
Looking at the map, the distance between the countries is big. Within the American continent, Mexico is the Spanish-speaking country that is farthest away from Brazil. But the two nations are closer to each other than it may seem. Fiocruz and Mexican institutions have joint projects, a cooperation that can expand even further, judging by the interest demonstrated by consul Héctor Humberto Valezzi Zafra.
Article
Data da publicação:
COVID-19 diagnostics, therapeutics, and vaccines are powerful reminders: health technologies can help to shape the way in which societies control disease. Challenges in ensuring global, equitable access to these fruits of biomedical research and development (R&D) during the COVID-19 pandemic have highlighted the urgency of reorienting the system towards the public interest. The first step is a clearer articulation of what R&D in the global public interest is.
Article
Data da publicação:
In a geopolitical context marked by disputes and inequalities, there are many economic, social, and environmental challenges in the path of those aiming to reduce these inequalities and achieve better global health outcomes. Based on this point of view, issues such as multilateralism and a possible new world order were discussed last Thursday (February 10) during the first Advanced Seminar in Global Health and Health Diplomacy this year. Promoted by the Fiocruz Global Health Center (CRIS/Fiocruz), the webinar brought together three specialists to discuss perspectives for 2022.
Article
Data da publicação:
A study analyzed the geographic distribution and the incidence of co-infection with a human T-lymphotropic virus (HTLV) and a human immunodeficiency virus (HIV) in Bahia, which is an endemic state for both retroviruses. The research was carried out using all samples submitted to serological tests at the Central Public Health Laboratory of Bahia (Lacen-BA), from 2004 to 2013.
Article
Data da publicação:
As reported by the State Health Secretariats of Rio de Janeiro and Santa Catarina, Fiocruz has identified three cases of the BA.2 lineage of the Omicron variant, using genetic sequencing. Two of the cases occurred in Rio de Janeiro and the other in the southern state of Santa Catarina.
Article
Data da publicação:
The Fiocruz Genomic Network has released new data on the status of lineages and variants of the Sars-CoV-2 in Brazil, based on the genomic surveillance produced by the Network and by other initiatives. According to the publication, while in December 39.4% of sequenced genomes belonged to the Omicron variant, in January 2022 this rate rose to 95.9%. The variant has now been found in all of the country’s regions. The Network Report shows that omicron now fully dominates the epidemiological scenario of Covid-19 in Brazil.
Article
Data da publicação:
Celebrated last Sunday (January 30), the World Neglected Tropical Diseases Day draws attention to infections that affect more than one billion people worldwide, and yet receive little in terms of attention and investment. These diseases, such as Chagas disease, dengue fever, leishmaniasis, hanseniasis, schistosomiasis and worm-related illnesses, affect mostly poor people, resulting in death or in great health problems, worsening people’s quality of life as they make it harder to remain in school and in the workforce.
Article
Data da publicação:
When a new advisory group of the World Health Organization (WHO) for neglected diseases holds its first meeting this Friday, January 1st, there will be a Brazilian in the room. Thiago Moreno L.
Article
Data da publicação:
Researchers of the Albert Einstein College of Medicine, in the United States, in a partnership with the Oswaldo Cruz Institute (IOC/Fiocruz) and with the University of São Paulo (USP) and other institutions, have given an important step towards the finding of a treatment for yellow fever. Considered a worldwide trend, synthetic monoclonal antibodies have been the subject of studies all over the planet.
Article
Data da publicação:
We all had some degree of hope that the end of 2021 and the beginning of 2022 would bring us the much-awaited retraction of the pandemic. However, the emergence of the new Omicron variant dragged us away from the end of the tunnel we were longing for. Many countries, including some with powerful health systems, excellent living conditions, and high levels of vaccination, are hitting record numbers of contagions every day.
Article
Data da publicação:
Science, technology and innovation to create resiliency, recover the planet from the impacts of COVID-19 and prepare it to face future health crises, including the ones resulting from environmental problems. This was the focus of the Global Sustainable Technology and Inovation Conference (G-Stic), an international reference in the debate that relates science, technology and innovation to the 2030 Agenda, which took place in Dubai from January 17th to 19th, 2022.
Article
Data da publicação:
At a moment in which the world is watching a new peak of COVID-19 cases, preliminary analysis of a study on safetey and immunogenicity indicate that the use of the AstraZeneca vaccine as a booster shot increases the immune response against the variants of concern Beta, Delta, Alpha, and Gamma. An analysis made separately with samples of the research also shows an increased response of antibodies against the Omicron variant, which is behind the new wave of the disease.
Article
Data da publicação:
This Friday (January 7), Fiocruz received assent from the National Agency of Sanitary Surveillance (Anvisa) for the alteration in the register of the COVID-19 vaccine (recombinant), which requested the addition of the Foundation as a producer of the Active Pharmaceutical Ingredient (API).
Article
Data da publicação:
A study published on medRXiv, this Wednesday (December 29th), shows that the four vaccines applied in Brazil provide a high degree of additional protection against symptomatic infections and severe cases of COVID-19 in people who had already contracted Sars-CoV-2 previously.
Article
Data da publicação:
A third AstraZeneca vaccine dose significantly increases neutralizing antibodies levels against the Ômicron variant (B.1.1.529), a new study indicates. The research was conducted independently by researchers from different institutions, including Fiocruz and Oxford University.
Article